Top Stock Losers (Quicksilver Resources Inc, ACADIA Pharmaceuticals Inc, ISIS Pharmaceuticals, Questcor Pharmaceuticals Inc)

Houston, TX -- (SBWIRE) -- 03/22/2013 -- AnotherWinningTrade.com offers its daily alerts and market content newsletter to investors looking for the best information available! AnotherWinningTrade.com provides its subscribers with useful, timely information and exclusive alerts on penny stocks, mid cap stocks and large cap stocks with the potential to deliver gains of 100%-200% or more. We have the top alerts in the industry. To receive our FREE, comprehensive newsletter, visit AnotherWinningTrade.com.

Quicksilver Resources Inc(NYSE:KWK) fell 7.23% and is trading at $2.31. Quicksilver Resources Inc. (Quicksilver) is an independent oil and gas company engaged primarily in the acquisition, exploration, development and production of onshore oil and gas in North America. The Company focuses primarily on unconventional reservoirs.

How Should Investors Trade KWK After The Solid Jump? Let’s Find Out Here

ACADIA Pharmaceuticals Inc.(NASDAQ:ACAD) is lower 7.16% and is trading at $7.65. ACADIA Pharmaceuticals Inc. is a biopharmaceutical company focused on small molecule drugs that address unmet medical needs in neurological and related central nervous system disorders.

Is ACAD Ready To Jump Again After The Solid Momentum? Get Free Trend Analysis Here

ISIS Pharmaceuticals, Inc.(NASDAQ:ISIS) fell 5.45% and is trading at $16.99. Isis Pharmaceuticals, Inc. develops therapeutic drugs inhibiting cell protein synthesis. The Company's principal activity is to develop and market RNA(RiboNucleicAcid)-based novel drugs to treat important diseases such as cardiovascular diseases, diabetes and asthma.

Is ISIS Buy After The Recent Price Movement? Find Out Here

Questcor Pharmaceuticals Inc(NASDAQ:QCOR) is lower 5.83% and is trading at $33.12. Questcor Pharmaceuticals, Inc. (Questcor) is a biopharmaceutical company. The Company’s primary product is H.P. Acthar Gel (repository corticotropin injection) (Acthar), an injectable drug that is approved by the United States Food and Drug Administration, for the treatment of 19 indications.

Is QCOR a Buy At The Current Market Price? Don’t Miss Out Our Special Coverage Here

Disclaimer
Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor’s reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid IO News Wire twelve hundred and ninety five dollars for the publication and circulation of this news release. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation; do no trading of any kind and send no faxes or emails.

Contact Information
Winning Media LLC
1-800-411-7716
ir@AnotherWinningTrade.com